drugset / Trial / NCT03738696
Liposomal Bupivacaine in Rotator Cuff Repair
Phase 4
Completed
64 enrolled
University of Alabama at Birmingham
Pacira Pharmaceuticals, Inc · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the efficacy of interscalene liposomal bupivacaine in controlling postoperative pain scores, oral morphine equivalents and sleep quality after arthroscopic rotator cuff repair surgery as compared to interscalene catheter.
Timeline
- Start
- 2019-12-15
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 133 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | 0.25 % | Other |